GSK plc Statistics
Total Valuation
GSK plc has a market cap or net worth of GBP 53.86 billion. The enterprise value is 66.15 billion.
Market Cap | 53.86B |
Enterprise Value | 66.15B |
Important Dates
The next estimated earnings date is Friday, January 31, 2025.
Earnings Date | Jan 31, 2025 |
Ex-Dividend Date | Nov 14, 2024 |
Share Statistics
GSK plc has 4.08 billion shares outstanding. The number of shares has increased by 0.71% in one year.
Current Share Class | n/a |
Shares Outstanding | 4.08B |
Shares Change (YoY) | +0.71% |
Shares Change (QoQ) | +0.46% |
Owned by Insiders (%) | 0.08% |
Owned by Institutions (%) | 85.78% |
Float | 3.95B |
Valuation Ratios
The trailing PE ratio is 21.71 and the forward PE ratio is 8.21. GSK plc's PEG ratio is 1.26.
PE Ratio | 21.71 |
Forward PE | 8.21 |
PS Ratio | 1.72 |
PB Ratio | 3.84 |
P/TBV Ratio | n/a |
P/FCF Ratio | 8.86 |
P/OCF Ratio | n/a |
PEG Ratio | 1.26 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.01, with an EV/FCF ratio of 10.88.
EV / Earnings | 26.35 |
EV / Sales | 2.11 |
EV / EBITDA | 7.01 |
EV / EBIT | 9.61 |
EV / FCF | 10.88 |
Financial Position
The company has a current ratio of 0.81, with a Debt / Equity ratio of 1.19.
Current Ratio | 0.81 |
Quick Ratio | 0.52 |
Debt / Equity | 1.19 |
Debt / EBITDA | 1.70 |
Debt / FCF | 2.64 |
Interest Coverage | 10.83 |
Financial Efficiency
Return on equity (ROE) is 21.85% and return on invested capital (ROIC) is 13.67%.
Return on Equity (ROE) | 21.85% |
Return on Assets (ROA) | 7.24% |
Return on Capital (ROIC) | 13.67% |
Revenue Per Employee | 445,949 |
Profits Per Employee | 35,763 |
Employee Count | 70,212 |
Asset Turnover | 0.53 |
Inventory Turnover | 1.52 |
Taxes
In the past 12 months, GSK plc has paid 754.00 million in taxes.
Income Tax | 754.00M |
Effective Tax Rate | 14.39% |
Stock Price Statistics
The stock price has decreased by -7.87% in the last 52 weeks. The beta is 0.31, so GSK plc's price volatility has been lower than the market average.
Beta (5Y) | 0.31 |
52-Week Price Change | -7.87% |
50-Day Moving Average | 1,379.55 |
200-Day Moving Average | 1,556.13 |
Relative Strength Index (RSI) | 40.41 |
Average Volume (20 Days) | 7,991,747 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, GSK plc had revenue of GBP 31.31 billion and earned 2.51 billion in profits. Earnings per share was 0.61.
Revenue | 31.31B |
Gross Profit | 22.67B |
Operating Income | 6.89B |
Pretax Income | 3.29B |
Net Income | 2.51B |
EBITDA | 9.26B |
EBIT | 6.89B |
Earnings Per Share (EPS) | 0.61 |
Balance Sheet
The company has 3.21 billion in cash and 16.06 billion in debt, giving a net cash position of -12.85 billion or -3.15 per share.
Cash & Cash Equivalents | 3.21B |
Total Debt | 16.06B |
Net Cash | -12.85B |
Net Cash Per Share | -3.15 |
Equity (Book Value) | 13.45B |
Book Value Per Share | 3.43 |
Working Capital | -4.16B |
Cash Flow
In the last 12 months, operating cash flow was 7.42 billion and capital expenditures -1.34 billion, giving a free cash flow of 6.08 billion.
Operating Cash Flow | 7.42B |
Capital Expenditures | -1.34B |
Free Cash Flow | 6.08B |
FCF Per Share | 1.49 |
Margins
Gross margin is 72.39%, with operating and profit margins of 22.00% and 8.02%.
Gross Margin | 72.39% |
Operating Margin | 22.00% |
Pretax Margin | 10.52% |
Profit Margin | 8.02% |
EBITDA Margin | 29.56% |
EBIT Margin | 22.00% |
FCF Margin | 19.42% |
Dividends & Yields
This stock pays an annual dividend of 0.58, which amounts to a dividend yield of 4.39%.
Dividend Per Share | 0.58 |
Dividend Yield | 4.39% |
Dividend Growth (YoY) | 9.42% |
Years of Dividend Growth | n/a |
Payout Ratio | 95.58% |
Buyback Yield | -0.71% |
Shareholder Yield | 3.68% |
Earnings Yield | n/a |
FCF Yield | n/a |
Stock Splits
The last stock split was on July 19, 2022. It was a reverse split with a ratio of 0.8.
Last Split Date | Jul 19, 2022 |
Split Type | Reverse |
Split Ratio | 0.8 |
Scores
GSK plc has an Altman Z-Score of 1.91 and a Piotroski F-Score of 7. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 1.91 |
Piotroski F-Score | 7 |